Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
Clinical trial NCT01365455 · COMPLETED
Trial details
- NCT number
- NCT01365455
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-04-01
- Enrollment
- 738
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.